Cargando…
Back to the Future: Lessons Learned in Modern Target-based and Whole-Cell Lead Optimization of Antimalarials
Antimalarial drug discovery has historically benefited from the whole-cell (phenotypic) screening approach to identify lead molecules in the search for new drugs. However over the past two decades there has been a shift in the pharmaceutical industry to move away from whole-cell screening to target-...
Autores principales: | Chatterjee, Arnab K, Yeung, Bryan KS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355380/ https://www.ncbi.nlm.nih.gov/pubmed/22242845 http://dx.doi.org/10.2174/156802612799362977 |
Ejemplares similares
-
Cell-based optimization of novel benzamides as potential antimalarial leads
por: Wu, Tao, et al.
Publicado: (2009) -
Imidazolopiperazines:
Lead Optimization of the Second-Generation Antimalarial Agents
por: Nagle, Advait, et al.
Publicado: (2012) -
Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents
por: Wu, Tao, et al.
Publicado: (2011) -
Antimalarial drug discovery: targeting the hypnozoite for new radical curative agent
por: Yeung, Bryan
Publicado: (2012) -
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
por: Short, Kirsty R., et al.
Publicado: (2018)